Intrauterine death from ergotamine overdosage.

Area of Science:

• Obstetrics and Gynecology
• Maternal-Fetal Medicine
• Clinical Toxicology

Background:

• Ergotamine tartrate is a medication used for treating migraines.
• Drug overdose during pregnancy poses significant risks to both mother and fetus.
• Primigravid patients represent a unique demographic in obstetric care.

Observation:

• A case of fetal death in a primigravid patient following an ergotamine tartrate overdose is presented.
• Cardiotocography showed frequent uterine contractions, though interpretation was limited.
• The clinical scenario points to a potential link between the overdose and fetal demise.

Findings:

• Fetal death occurred in the context of ergotamine tartrate overdosage.
• Uterine hyperstimulation was a noted observation during monitoring.
• The study discusses the potential mechanisms leading to fetal death.

Implications:

• Ergotamine tartrate overdosage should be recognized as a critical threat to fetal well-being.
• Clinicians must be vigilant regarding ergotamine use and potential toxicity in pregnant patients.
• This case underscores the importance of careful medication management during pregnancy.